CIK: 1826322 - Address: C/o Essa Pharma Inc., 999 West Broadway, Suite 720, Vancouver, A1 V5Z 1K5
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/6/24 17:17
5/6/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS-56.950-1-611D
4/5/24 18:16
4/5/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS-67.940-1-512D
3/5/24 18:50
3/5/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS-68.980-1-513D
2/7/24 11:29
2/6/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOM.d2353.2307313D
2/7/24 11:29
2/6/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS.d-74910.290-73-8513D
2/6/24 08:27
2/5/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS.d-119.580-1-813D
2/6/24 08:27
2/5/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOM.d23.2301413D
1/17/24 20:57
1/16/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOM.d63.23021414D
1/17/24 20:57
1/16/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS.d-1710.010-2-1114D
1/8/24 20:06
1/5/24
EPIXEssa Pharma Inc.A1HealthDrugPharmaceutical PreparationsVirsik PeterA1OCOOS-46.110-1-514D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact